Schonfeld Strategic Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $24.1M | Buy |
26,237
+25,811
| +6,059% | +$26.2M | 0.17% | 116 |
|
|
2025
Q4 | $458K | Sell |
426
-223,023
| -100% | -$213M | ﹤0.01% | 1424 |
|
|
2025
Q3 | $18M | Buy |
223,449
+128,400
| +135% | +$95.6M | 0.1% | 209 |
|
|
2025
Q2 | $74.1M | Buy |
95,049
+70,502
| +287% | +$54.8M | 0.5% | 20 |
|
|
2025
Q1 | $20.3M | Buy |
24,547
+3,528
| +17% | +$2.94M | 0.12% | 166 |
|
|
2024
Q4 | $16.2M | Buy |
21,019
+5,539
| +36% | +$4.59M | 0.09% | 187 |
|
|
2024
Q3 | $13.7M | Buy |
15,480
+8,010
| +107% | +$7.2M | 0.09% | 223 |
|
|
2024
Q2 | $6.76M | Sell |
7,470
-3,593
| -32% | -$2.87M | 0.04% | 473 |
|
|
2024
Q1 | $8.61M | Buy |
11,063
+9,818
| +789% | +$6.99M | 0.06% | 428 |
|
|
2023
Q4 | $726K | Sell |
1,245
-74,474
| -98% | -$43.5M | ﹤0.01% | 1153 |
|
|
2023
Q3 | $40.7M | Buy |
75,719
+49,593
| +190% | +$25.6M | 0.32% | 56 |
|
|
2023
Q2 | $12.3M | Buy |
26,126
+25,826
| +8,609% | +$10.8M | 0.11% | 299 |
|
|
2023
Q1 | $103K | Sell |
300
-5,183
| -95% | -$1.75M | ﹤0.01% | 1687 |
|
|
2022
Q4 | $2.01M | Buy |
5,483
+1,183
| +28% | +$419K | 0.02% | 819 |
|
|
2022
Q3 | $1.39M | Sell |
4,300
-18,321
| -81% | -$5.8M | 0.01% | 1066 |
|
|
2022
Q2 | $7.33M | Buy |
+22,621
| New | +$6.79M | 0.07% | 354 |
|
|
2022
Q1 | – | Sell |
-9,418
| Closed | -$2.6M | – | 2775 |
|
|
2021
Q4 | $2.6M | Sell |
9,418
-2,152
| -19% | -$546K | 0.02% | 635 |
|
|
2021
Q3 | $2.67M | Sell |
11,570
-56,757
| -83% | -$14M | 0.03% | 617 |
|
|
2021
Q2 | $15.7M | Buy |
+68,327
| New | +$13.7M | 0.17% | 176 |
|
|
2021
Q1 | – | Sell |
-23,700
| Closed | -$4M | – | 1990 |
|
|
2020
Q4 | $4M | Sell |
23,700
-27,329
| -54% | -$4.08M | 0.05% | 452 |
|
|
2020
Q3 | $7.55M | Buy |
51,029
+45,709
| +859% | +$7.07M | 0.14% | 202 |
|
|
2020
Q2 | $873K | Buy |
+5,320
| New | +$817K | 0.02% | 641 |
|
|
2020
Q1 | – | Sell |
-4,934
| Closed | -$648K | – | 1349 |
|
|
2019
Q4 | $648K | Sell |
4,934
-7,970
| -62% | -$924K | 0.02% | 649 |
|
|
2019
Q3 | $1.44M | Buy |
12,904
+6,004
| +87% | +$668K | 0.04% | 387 |
|
|
2019
Q2 | $764K | Sell |
6,900
-7,571
| -52% | -$892K | 0.03% | 519 |
|
|
2019
Q1 | $1.88M | Buy |
+14,471
| New | +$1.76M | 0.07% | 355 |
|
|
2017
Q4 | – | Sell |
-39,773
| Closed | -$3.4M | – | 818 |
|
|
2017
Q3 | $3.4M | Buy |
+39,773
| New | +$3.26M | 0.31% | 104 |
|
|
2017
Q2 | – | Sell |
-75,000
| Closed | -$6.31M | – | 698 |
|
|
2017
Q1 | $6.31M | Sell |
75,000
-71,398
| -49% | -$5.72M | 0.63% | 30 |
|
|
2016
Q4 | $10.8M | Buy |
+146,398
| New | +$10.9M | 1.39% | 2 |
|
Other funds holding LLY
VCM
VPM
Schonfeld Strategic Advisors's LLY Position: Q1 2026 in Review
Schonfeld Strategic Advisors increased its Eli Lilly (LLY) stake by 6,059% in Q1 2026, buying an estimated $26.2M and bringing the position to 26,237 shares worth $24.1M. The position accounts for 0.17% of the portfolio, ranked #116.
Schonfeld Strategic Advisors first reported a position in LLY in Q4 2016 and has held it in 29 quarters since. The position peaked at $74.1M in Q2 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Schonfeld Strategic Advisors held 26,237 shares of Eli Lilly worth $24.1M as of Q1 2026.
- Schonfeld Strategic Advisors bought 25,811 Eli Lilly shares in Q1 2026, an estimated $26.2M.
- Eli Lilly made up 0.17% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #116 holding.
- Schonfeld Strategic Advisors first reported a position in Eli Lilly in Q4 2016 and has held it in 29 quarters since.
- Schonfeld Strategic Advisors's Eli Lilly position peaked at $74.1M in Q2 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.